Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Cancer|August 15, 1986
Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer. A randomized controlled studyK Okamura, M Suzuki, T Chihara, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|May 1, 1984
[Standardized radiation treatment method for carcinoma of the uterine cervix]T Arai, A Akanuma, M Ikeda, et al.
Japanese Journal of Clinical Oncology|December 1, 1988
The increasing trend in Japan of müllerian mixed tumor of endometriumT Kato, S Teshima, S Watanabe, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2002
Immature glandular features in squamous cell carcinoma of the uterine cervix as an independent indicator of resistance to radiotherapyS Okada, Hitoshi Tsuda, K Ohmi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 25, 2001
Primary epithelioid sarcoma of the vulvaT Kasamatsu, T Hasegawa, H Tsuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1988
[Phase III study of carboplatin in ovarian cancer]T Kato, H Nishimura, T Yamabe, et al.
Journal of Human Hypertension|October 1, 1989
Urinary sodium and potassium excretion, body mass index, alcohol intake and blood pressure in three Japanese populationsT Hashimoto, Y Fujita, H Ueshima, et al.
Japanese Journal of Clinical Oncology|February 1, 1992
Clinical effect of sizofiran combined with irradiation in cervical cancer patients: a randomized controlled study. Cooperative Study Group on SPG for Gynecological CancerK Noda, S Takeuchi, A Yajima, et al.
Anticancer Research|September 1, 1996
Tamoxifen mediated human endometrial carcinogenesis may not involve estrogenic pathways: a preliminary noteY Kuwashima, M Kurosumi, Y Kobayashi, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1989
Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rateK Okamura, M Suzuki, T Chihara, et al.
Pageof 19